Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.38%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +22.68%
#5 Tutorial Tutorial +22.05%
#6 Codatta Codatta +16.69%
#7 Humanity Humanity +16.02%
#8 Ribbita by Virtuals Ribbita by Virtuals +14.73%
#9 Enso Enso +14.41%
#10 Cysic Cysic +12.50%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Classifica tra le azioni #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Prezzo delle azioni
$3.92
Ultima sincronizzazione: 2025-08-14
Capitalizzazione di mercato
$2.34M
Variazione (1 giorno)
-69.38%
Variazione (1 anno)
0.00%
Paese
US
Scambia ReShape Lifesciences Inc. (RSLS)

Categoria

Healthcare
Il prezzo RSLS con la capitalizzazione del mercato della B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Capitalizzazione di mercato di ReShape Lifesciences Inc.(RSLS)
Capitalizzazione di mercato: $2.34M
A partire dal August 2026, ReShape Lifesciences Inc. ha una capitalizzazione di mercato pari a $2.34M. Questo rende ReShape Lifesciences Inc. la 36770th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di ReShape Lifesciences Inc. dal 2019 al 2026
RSLS in paragone con la classifica dei più popolari stocks
Il prezzo per RSLS Attivo B Capitalizzazione del mercato a B Risultati
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
Apple Inc. Apple Inc.
AAPL
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +121,156,629.05%